Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology

被引:18
|
作者
Caldwell, Jamie M. [1 ]
Le, Xuan [2 ]
McIntosh, Lorin [2 ]
Meehan, Michael T. [3 ]
Ogunlade, Samson [3 ]
Ragonnet, Romain [2 ]
O'Neill, Genevieve K. [2 ]
Trauer, James M. [2 ]
McBryde, Emma S. [3 ]
机构
[1] Univ Hawaii Manoa, Dept Biol, Honolulu, HI USA
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Epidemiol Modelling Unit, Melbourne, Vic, Australia
[3] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia
关键词
COVID-19; Mathematical modelling; Herd immunity threshold; Variants of Concern; Vaccine allocation; Educational aims; Future directions for research; SARS-COV-2; PRIORITIZATION; IMPACT; AGE;
D O I
10.1016/j.prrv.2021.07.002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Mathematical modelling has played a pivotal role in understanding the epidemiology of and guiding pub-lic health responses to the ongoing coronavirus disease of 2019 (COVID-19) pandemic. Here, we review the role of epidemiological models in understanding evolving epidemic characteristics, including the effects of vaccination and Variants of Concern (VoC). We highlight ways in which models continue to pro-vide important insights, including (1) calculating the herd immunity threshold and evaluating its limita-tions; (2) verifying that nascent vaccines can prevent severe disease, infection, and transmission but may be less efficacious against VoC; (3) determining optimal vaccine allocation strategies under efficacy and supply constraints; and (4) determining that VoC are more transmissible and lethal than previously cir-culating strains, and that immune escape may jeopardize vaccine-induced herd immunity. Finally, we explore how models can help us anticipate and prepare for future stages of COVID-19 epidemiology (and that of other diseases) through forecasts and scenario projections, given current uncertainties and data limitations. (c) 2021 Published by Elsevier Ltd.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [1] Covid-19: virology, variants, and vaccines
    Young, Megan
    Crook, Harry
    Scott, Janet
    Edison, Paul
    BMJ MEDICINE, 2022, 1 (01):
  • [3] COVID-19 Vaccines and the Efficacy of Currently Available Vaccines Against COVID-19 Variants
    Selvam, Suganya Panneer
    Ramani, Pratibha
    Ramya, R.
    Sundar, Sandhya
    Lakshmi, T. A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [4] COVID-19: Insights into Potential Vaccines
    Loo, Ke-Yan
    Letchumanan, Vengadesh
    Ser, Hooi-Leng
    Teoh, Siew Li
    Law, Jodi Woan-Fei
    Tan, Loh Teng-Hern
    Ab Mutalib, Nurul-Syakima
    Chan, Kok-Gan
    Lee, Learn-Han
    MICROORGANISMS, 2021, 9 (03) : 1 - 19
  • [5] COVID-19: vaccines, efficacy and effects on variants
    Rudan, Igor
    Adeloye, Davies
    Sheikh, Aziz
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (03) : 180 - 191
  • [6] Covid-19: Where are we on vaccines and variants?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n597
  • [7] Covid-19 vaccines and variants of concern: A review
    Hassine, Ikbel Hadj
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (04)
  • [8] Covid-19 Vaccines - Immunity, Variants, Boosters
    Barouch, Dan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1011 - 1020
  • [9] Emerging COVID-19 vaccines: A rheumatology perspective
    Byravan, Swetha
    Fardanesh, Armin
    Tahir, Hasan
    Moorthy, Arumugam
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (02) : 144 - 146
  • [10] Modelling insights into the COVID-19 pandemic
    Meehan, Michael T.
    Rojas, Diana P.
    Adekunle, Adeshina, I
    Adegboye, Oyelola A.
    Caldwell, Jamie M.
    Turek, Evelyn
    Williams, Bridget M.
    Marais, Ben J.
    Trauer, James M.
    McBryde, Emma S.
    PAEDIATRIC RESPIRATORY REVIEWS, 2020, 35 : 64 - 69